Syndromes of Enteric Infection

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 1, Issue , 2014, Pages 1238-1247

  LaRocque, Regina C ^a,b   Calderwood, Stephen B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diarrhea; Dysentery; Enteric infections; Enterotoxins; Food borne illness; Gastroenteritis; Gastrointestinal infections; Intestinal immunity; Microbial pathogenesis; Traveler's diarrhea

Indexed keywords

EID: 84937533995     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00098-9     Document Type: Chapter

References (204)

1. Baqui AH, Black RE, Yunus M, et al. Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol 1991, 20:1057-1063.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2095-2128.
3. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
4. Fischer Walker CL, Perin J, Aryee MJ, et al. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health 2012, 12:220.
5. Checkley W, Buckley G, Gilman RH, et al. Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol 2008, 37:816-830.
6. Guerrant DI, Moore SR, Lima AA, et al. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999, 61:707-713.
7. Niehaus MD, Moore SR, Patrick PD, et al. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg 2002, 66:590-593.
8. Wikswo ME, Hall AJ Outbreaks of acute gastroenteritis transmitted by person-to-person contact-United States, 2009-2010. MMWR Surveill Summ 2012, 61:1-12. Centers for Disease Control and Prevention.
9. Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013, 368:1121-1130.
10. Glass RI, Parashar UD, Estes MK Norovirus gastroenteritis. N Engl J Med 2009, 361:1776-1785.
11. Parashar UD, Alexander JP, Glass RI Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55:1-13. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC).
12. Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011, 365:1108-1117.
13. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011, 30:S56-S60.
14. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
15. Scallan E, Griffin PM, Angulo FJ, et al. Foodborne illness acquired in the United States-unspecified agents. Emerg Infect Dis 2011, 17:16-22.
16. Batz MB, Hoffmann S, Morris JG Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot 2012, 75:1278-1291.
17. Buchholz U, Bernard H, Werber D, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011, 365:1763-1770.
18. Rasko DA, Webster DR, Sahl JW, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 2011, 365:709-717.
19. Frank C, Werber D, Cramer JP, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011, 365:1771-1780.
20. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
21. Hogenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 2006, 355:2418-2426.
22. Larson HE, Borriello SP Infectious diarrhea due to Clostridium perfringens. J Infect Dis 1988, 157:390-391.
23. Lopman BA, Reacher MH, Vipond IB, et al. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis 2004, 39:318-324.
24. Levine MM, Kotloff KL, Nataro JP, Muhsen K The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis. Clin Infect Dis 2012, 55(suppl 4):S215-S224.
25. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983, 308:681-685.
26. Skirrow MB Campylobacter enteritis: a "new" disease. Br Med J 1977, 2:9-11.
27. Kendall ME, Crim S, Fullerton K, et al. Travel-associated enteric infections diagnosed after return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009. Clin Infect Dis 2012, 54(suppl 5):S480-S487.
28. Painter JA, Hoekstra RM, Ayers T, et al. Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008. Emerg Infect Dis 2013, 19:407-415.
29. FDA Report on the Occurrence of Foodborne Illness Risk Factors in Selected Institutional Foodservice, Restaurant, and Retail Food Store Facility Types (2009) 2009, Silver Spring, MD: U.S. Department of Health and Human Services, Food and Drug Administration.
30. Lal A, Hales S, French N, Baker MG Seasonality in human zoonotic enteric diseases: a systematic review. PLoS One 2012, 7:e31883.
31. Schwartz BS, Harris JB, Khan AI, et al. Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am J Trop Med Hyg 2006, 74:1067-1073.
32. Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011, 11(suppl 3):S15.
33. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005, 135:1304-1307.
34. Department of Nutrition for Health and Development Report of the Expert Consultation on the Optimal Duration of Exclusive Breastfeeding 2001, World Health Organization, Geneva, Switzerland.
35. Skirrow MB A demographic survey of Campylobacter, Salmonella and Shigella infections in England: a Public Health Laboratory Service survey. Epidemiol Infect 1987, 99:647-657.
36. Trevejo RT, Courtney JG, Starr M, Vugia DJ Epidemiology of salmonellosis in California, 1990-1999: morbidity, mortality, and hospitalization costs. Am J Epidemiol 2003, 157:48-57.
37. Barton Behravesh C, Jones TF, Vugia DJ, et al. Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005. J Infect Dis 2011, 204:263-267.
38. Louie TJ, Miller MA, Crook DW, et al. Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc 2013, 61:222-230.
39. Zilberberg MD, Shorr AF, Micek ST, et al. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med 2009, 37:2583-2589.
40. Pouillot R, Hoelzer K, Jackson KA, et al. Relative risk of listeriosis in Foodborne Diseases Active Surveillance Network (FoodNet) sites according to age, pregnancy, and ethnicity. Clin Infect Dis 2012, 54(suppl 5):S405-S410.
41. Cardemil CV, Cortese MM, Medina-Marino A, et al. Two rotavirus outbreaks caused by genotype G2P[4] at large retirement communities: cohort studies. Ann Intern Med 2012, 157:621-631.
42. Giannella R, Broitman S, Zamcheck N The gastric barrier to microorganisms in man: in vivo and in vitro studies. Gut 1972, 13:251-256.
43. Bavishi C, Dupont HL Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011, 34:1269-1281.
44. Swaddiwudhipong W, Kunasol P An outbreak of nosocomial cholera in a 755-bed hospital. Trans R Soc Trop Med Hyg 1989, 83:279-281.
45. Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, et al. Risk factors for Salmonella enteritidis and typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in enteritidis and sandboxes in typhimurium infections. Epidemiol Infect 2006, 134:617-626.
46. Neal KR, Scott HM, Slack RC, Logan RF Omeprazole as a risk factor for Campylobacter gastroenteritis: case-control study. BMJ 1996, 312:414-415.
47. Ho JL, Shands KN, Friedland G, et al. An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med 1986, 146:520-524.
48. DuPont HL, Hornick RB Adverse effect of Lomotil therapy in shigellosis. JAMA 1973, 226:1525-1528.
49. Church JM, Fazio VW A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Dis Colon Rectum 1986, 29:804-809.
50. Brearly S, Armstrong GR, Nairn R, et al. Pseudomembranous colitis: a lethal complication of Hirschsprung's disease unrelated to antibiotic usage. J Pediatr Surg 1987, 22:257-259.
51. McGregor A, Brown M, Thway K, Wright SG Fulminant amoebic colitis following loperamide use. J Travel Med 2007, 14:61-62.
52. Turnbaugh PJ, Gordon JI The core gut microbiome, energy balance and obesity. J Physiol 2009, 587:4153-4158.
53. Dave M, Higgins PD, Middha S, Rioux KP The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 2012, 160:246-257.
54. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008, 197:435-438.
55. Krones E, Hogenauer C Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 2012, 41:677-701.
56. Mejia R, Nutman TB Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 2012, 25:458-463.
57. Bok K, Green KY Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012, 367:2126-2132.
58. Jiang ZD, DuPont HL, Garey K, et al. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol 2006, 101:1112-1116.
59. Jiang ZD, Okhuysen PC, Guo DC, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis 2003, 188:506-511.
60. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, et al. Assessment of the Toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 2007, 7:70.
61. Harris JB, Khan AI, Larocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun 2005, 73:7422-7427.
62. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003, 9:548-553.
63. Marionneau S, Ruvoen N, Le Moullac-Vaidye B, et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002, 122:1967-1977.
64. Kossmann J, Nestel P, Herrera MG, et al. Undernutrition in relation to childhood infections: a prospective study in the Sudan. Eur J Clin Nutr 2000, 54:463-472.
65. Mondal D, Haque R, Sack RB, et al. Attribution of malnutrition to cause-specific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg 2009, 80:824-826.
66. Opintan JA, Newman MJ, Ayeh-Kumi PF, et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg 2010, 83:936-943.
67. Tseng TT, Tyler BM, Setubal JC Protein secretion systems in bacterial-host associations, and their description in the gene ontology. BMC Microbiol 2009, 9(suppl 1):S2.
68. Finlay BB, Cossart P Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997, 276:718-725.
69. Mekalanos JJ Environmental signals controlling expression of virulence determinants in bacteria. J Bacteriol 1992, 174:1-7.
70. Lin J, Smith MP, Chapin KC, et al. Mechanisms of acid resistance in enterohemorrhagic Escherichia coli. Appl Environ Microbiol 1996, 62:3094-3100.
71. DuPont HL, Levine MM, Hornick RB, Formal SB Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989, 159:1126-1128.
72. Mead PS, Griffin PM Escherichia coli O157:H7. Lancet 1998, 352:1207-1212.
73. Proft T, Baker EN Pili in gram-negative and gram-positive bacteria-structure, assembly and their role in disease. Cell Mol Life Sci 2009, 66:613-635.
74. Giron JA, Ho AS, Schoolnik GK An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 1991, 254:710-713.
75. Qadri F, Svennerholm AM, Faruque AS, Sack RB Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005, 18:465-483.
76. Nataro JP, Steiner T, Guerrant RL Enteroaggregative Escherichia coli. Emerg Infect Dis 1998, 4:251-261.
77. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci U S A 1987, 84:2833-2837.
78. Jerse AE, Yu J, Tall BD, Kaper JB A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 1990, 87:7839-7843.
79. Galan JE, Collmer A Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999, 284:1322-1328.
80. Kalman D, Weiner OD, Goosney DL, et al. Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nat Cell Biol 1999, 1:389-391.
81. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 1995, 92:1664-1668.
82. Francis CL, Ryan TA, Jones BD, et al. Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria. Nature 1993, 364:639-642.
83. Alpuche-Aranda CM, Berthiaume EP, Mock B, et al. Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Infect Immun 1995, 63:4456-4462.
84. Hensel M, Shea JE, Waterman SR, et al. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol 1998, 30:163-174.
85. Miller SI, Kukral AM, Mekalanos JJ A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A 1989, 86:5054-5058.
86. Guo L, Lim KB, Poduje CM, et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998, 95:189-198.
87. Schroeder GN, Hilbi H Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008, 21:134-156.
88. Ogawa M, Handa Y, Ashida H, et al. The versatility of Shigella effectors. Nat Rev Microbiol 2008, 6:11-16.
89. Bernardini ML, Mounier J, d'Hauteville H, et al. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. Proc Natl Acad Sci U S A 1989, 86:3867-3871.
90. Lundgren O, Peregrin AT, Persson K, et al. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000, 287:491-495.
91. Balaban N, Rasooly A Staphylococcal enterotoxins. Int J Food Microbiol 2000, 61:1-10.
92. Schoeni JL, Wong AC Bacillus cereus food poisoning and its toxins. J Food Prot 2005, 68:636-648.
93. Katahira J, Sugiyama H, Inoue N, et al. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997, 272:26652-26658.
94. Sobel J, Painter J Illnesses caused by marine toxins. Clin Infect Dis 2005, 41:1290-1296.
95. Cherington M Botulism: update and review. Semin Neurol 2004, 24:155-163.
96. Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet 2012, 379:2466-2476.
97. Gill DM, Meren R ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase. Proc Natl Acad Sci U S A 1978, 75:3050-3054.
98. Waldor MK, Mekalanos JJ Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996, 272:1910-1914.
99. Forte LR, Currie MG Guanylin: a peptide regulator of epithelial transport. FASEB J 1995, 9:643-650.
100. Bergan J, Dyve Lingelem AB, Simm R, et al. Shiga toxins. Toxicon 2012, 60:1085-1107.
101. Sandvig K, Garred O, Prydz K, et al. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 1992, 358:510-512.
102. Endo Y, Tsurugi K, Yutsudo T, et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988, 171:45-50.
103. Karmali MA, Petric M, Lim C, et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. J Infect Dis 2004, 189:556-563.
104. Pickett CL, Pesci EC, Cottle DL, et al. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun 1996, 64:2070-2078.
105. Spano S, Ugalde JE, Galan JE Delivery of a Salmonella typhi exotoxin from a host intracellular compartment. Cell Host Microbe 2008, 3:30-38.
106. Raimondi F, Kao JP, Fiorentini C, et al. Enterotoxicity and cytotoxicity of Vibrio parahaemolyticus thermostable direct hemolysin in in vitro systems. Infect Immun 2000, 68:3180-3185.
107. Voth DE, Ballard JD Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18:247-263.
108. Just I, Selzer J, Wilm M, et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995, 375:500-503.
109. Long-Krug SA, Fischer KJ, Hysmith RM, Ravdin JI Phospholipase A enzymes of Entamoeba histolytica: description and subcellular localization. J Infect Dis 1985, 152:536-541.
110. Desai R, Hembree CD, Handel A, et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012, 55:189-193.
111. Uhnoo I, Wadell G, Svensson L, Johansson ME Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol 1984, 20:365-372.
112. Nair GB, Ramamurthy T, Bhattacharya MK, et al. Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India. Gut Pathog 2010, 2:4.
113. Nelson EJ, Nelson DS, Salam MA, Sack DA Antibiotics for both moderate and severe cholera. N Engl J Med 2011, 364:5-7.
114. Boyce TG, Swerdlow DL, Griffin PM Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995, 333:364-368.
115. Mintz E A riddle wrapped in a mystery inside an enigma: Brainerd diarrhoea turns 20. Lancet 2003, 362:2037-2038.
116. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002, 347:1770-1782.
117. Khan WA, Dhar U, Salam MA, et al. Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome. Pediatrics 1999, 103:E18.
118. Garg AX, Pope JE, Thiessen-Philbrook H, et al. Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford) 2008, 47:200-204. Walkerton Health Study Investigators.
119. Jacobs BC, Hazenberg MP, van Doorn PA, et al. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis 1997, 175:729-733.
120. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligo-saccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A 2004, 101:11404-11409.
121. Levine MM, Robins-Browne RM Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis 2012, 55(suppl 4):S303-S311.
122. Levine MM, DuPont HL, Khodabandelou M, Hornick RB Long-term Shigella-carrier state. N Engl J Med 1973, 288:1169-1171.
123. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001, 32:331-351.
124. McFarland LV, Mulligan ME, Kwok RY, Stamm WE Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989, 320:204-210.
125. Polage CR, Solnick JV, Cohen SH Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis 2012, 55:982-989.
126. Rohner P, Pittet D, Pepey B, et al. Etiological agents of infectious diarrhea: implications for requests for microbial culture. J Clin Microbiol 1997, 35:1427-1432.
127. Church DL, Cadrain G, Kabani A, et al. Practice guidelines for ordering stool cultures in a pediatric population. Alberta Children's Hospital, Calgary, Alberta, Canada. Am J Clin Pathol 1995, 103:149-153.
128. Kotton CN, Lankowski AJ, Hohmann EL Comparison of rectal swabs with fecal cultures for detection of Salmonella typhimurium in adult volunteers. Diagn Microbiol Infect Dis 2006, 56:123-126.
129. Rishmawi N, Ghneim R, Kattan R, et al. Survival of fastidious and nonfastidious aerobic bacteria in three bacterial transport swab systems. J Clin Microbiol 2007, 45:1278-1283.
130. Bauer TM, Lalvani A, Fehrenbach J, et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001, 285:313-319.
131. Victora CG, Bryce J, Fontaine O, Monasch R Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000, 78:1246-1255.
132. Brown KH, Gastanaduy AS, Saavedra JM, et al. Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children. J Pediatr 1988, 112:191-200.
133. Christopher PR, David KV, John SM, Sankarapandian V Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2009, (4).
134. DuPont HL, Ericsson CD Prevention and treatment of traveler's diarrhea. N Engl J Med 1993, 328:1821-1827.
135. Ternhag A, Asikainen T, Giesecke J, Ekdahl K A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis 2007, 44:696-700.
136. Onwuezobe IA, Oshun PO, Odigwe CC Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012, (11).
137. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000, 342:1930-1936.
138. Wong CS, Mooney JC, Brandt JR, et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 2012, 55:33-41.
139. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Anti-microbial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005, 5:481-493.
140. Kariuki S, Hart CA Global aspects of antimicrobial-resistant enteric bacteria. Curr Opin Infect Dis 2001, 14:579-586.
141. Mandomando I, Espasa M, Valles X, et al. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhica District Hospital, southern Mozambique. J Antimicrob Chemother 2007, 60:662-664.
142. Taneja N, Mohan B, Khurana S, Sharma M Antimicrobial resistance in selected bacterial enteropathogens in north India. Indian J Med Res 2004, 120:39-43.
143. Rahman M, Shoma S, Rashid H, et al. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr 2007, 25:158-167.
144. Tjaniadi P, Lesmana M, Subekti D, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 2003, 68:666-670.
145. Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med 2000, 342:1242-1249.
146. DuPont HL Clinical practice. Bacterial diarrhea. N Engl J Med 2009, 361:1560-1569.
147. Nelson JM, Griffin PM, Jones TF, et al. Antimicrobial and antimotility agent use in persons with Shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites. Clin Infect Dis 2011, 52:1130-1132.
148. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for self-therapy of travelers' diarrhea. J Travel Med 2009, 16:161-171.
149. Curtis V, Cairncross S Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis 2003, 3:275-281.
150. Clasen T, Schmidt WP, Rabie T, et al. Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis. BMJ 2007, 334:782.
151. Lucas ME, Deen JL, von Seidlein L, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005, 352:757-767.
152. Sur D, Ochiai RL, Bhattacharya SK, et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009, 361:335-344.
153. Fraser A, Goldberg E, Acosta CJ, et al. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2007, (3).
154. Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011, 365:2178-2187.
155. Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001, 344:1263-1269.
156. Fischer Walker CL, Perin J, Aryee MJ, et al. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health 2012, 12:220.
157. Wikswo ME, Hall AJ Outbreaks of acute gastroenteritis transmitted by person-to-person contact-United States, 2009-2010. MMWR Surveill Summ 2012, 61:1-12. Centers for Disease Control and Prevention.
158. Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013, 368:1121-1130.
159. Glass RI, Parashar UD, Estes MK Norovirus gastroenteritis. N Engl J Med 2009, 361:1776-1785.
160. Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011, 365:1108-1117.
161. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
162. Scallan E, Griffin PM, Angulo FJ, et al. Foodborne illness acquired in the United States-unspecified agents. Emerg Infect Dis 2011, 17:16-22.
163. Batz MB, Hoffmann S, Morris JG Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot 2012, 75:1278-1291.
164. Buchholz U, Bernard H, Werber D, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011, 365:1763-1770.
165. Rasko DA, Webster DR, Sahl JW, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 2011, 365:709-717.
166. Frank C, Werber D, Cramer JP, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011, 365:1771-1780.
167. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
168. Kendall ME, Crim S, Fullerton K, et al. Travel-associated enteric infections diagnosed after return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009. Clin Infect Dis 2012, 54(suppl 5):S480-S487.
169. Painter JA, Hoekstra RM, Ayers T, et al. Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008. Emerg Infect Dis 2013, 19:407-415.
170. Lal A, Hales S, French N, Baker MG Seasonality in human zoonotic enteric diseases: a systematic review. PLoS One 2012, 7:e31883.
171. Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011, 11(suppl 3):S15.
172. Barton Behravesh C, Jones TF, Vugia DJ, et al. Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005. J Infect Dis 2011, 204:263-267.
173. Louie TJ, Miller MA, Crook DW, et al. Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc 2013, 61:222-230.
174. Pouillot R, Hoelzer K, Jackson KA, et al. Relative risk of listeriosis in Foodborne Diseases Active Surveillance Network (FoodNet) sites according to age, pregnancy, and ethnicity. Clin Infect Dis 2012, 54(suppl 5):S405-S410.
175. Cardemil CV, Cortese MM, Medina-Marino A, et al. Two rotavirus outbreaks caused by genotype G2P[4] at large retirement communities: cohort studies. Ann Intern Med 2012, 157:621-631.
176. Bavishi C, Dupont HL Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011, 34:1269-1281.
177. Turnbaugh PJ, Gordon JI The core gut microbiome, energy balance and obesity. J Physiol 2009, 587:4153-4158.
178. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008, 197:435-438.
179. Krones E, Hogenauer C Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 2012, 41:677-701.
180. Mejia R, Nutman TB Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 2012, 25:458-463.
181. Bok K, Green KY Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012, 367:2126-2132.
182. Finlay BB, Cossart P Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997, 276:718-725.
183. Qadri F, Svennerholm AM, Faruque AS, Sack RB Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005, 18:465-483.
184. Galan JE, Collmer A Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999, 284:1322-1328.
185. Schroeder GN, Hilbi H Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008, 21:134-156.
186. Lundgren O, Peregrin AT, Persson K, Kordasti S, et al. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000, 287:491-495.
187. Sobel J, Painter J Illnesses caused by marine toxins. Clin Infect Dis 2005, 41:1290-1296.
188. Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet 2012, 379:2466-2476.
189. Voth DE, Ballard JD Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18:247-263.
190. Desai R, Hembree CD, Handel A, et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012, 55:189-193.
191. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002, 347:1770-1782.
192. Garg AX, Pope JE, Thiessen-Philbrook H, et al. Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford) 2008, 47:200-204. Walkerton Health Study Investigators.
193. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001, 32:331-351.
194. Polage CR, Solnick JV, Cohen SH Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis 2012, 55:982-989.
195. Church DL, Cadrain G, Kabani A, et al. Practice guidelines for ordering stool cultures in a pediatric population. Alberta Children's Hospital, Calgary, Alberta, Canada. Am J Clin Pathol 1995, 103:149-153.
196. Christopher PR, David KV, John SM, Sankarapandian V Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2009, (4).
197. Ternhag A, Asikainen T, Giesecke J, Ekdahl K A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis 2007, 44:696-700.
198. Onwuezobe IA, Oshun PO, Odigwe CC Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012, (11).
199. Wong CS, Mooney JC, Brandt JR, et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 2012, 55:33-41.
200. Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med 2000, 342:1242-1249.
201. DuPont HL Clinical practice. Bacterial diarrhea. N Engl J Med 2009, 361:1560-1569.
202. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for self-therapy of travelers' diarrhea. J Travel Med 2009, 16:161-171.
203. Clasen T, Schmidt WP, Rabie T, et al. Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis. BMJ 2007, 334:782.
204. Fraser A, Goldberg E, Acosta CJ, et al. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2007, (3).